FDA’s authorization of convalescent plasma has been one of the agency’s most controversial decisions during COVID-19 • Source: Nielsen Hobbs for Informa| Alamy, FDA images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
